Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Gardner

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Open Forum Infectious Diseases|July 26, 2019
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP CareKevin F Kamis, Grace E Marx, Kenneth A Scott, et al.
Journal of the International Association of Providers of AIDS Care|August 22, 2013
Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, ColoradoEdward M Gardner, Elaine Daniloff, Mark W Thrun, et al.
Immunobiology|September 17, 2018
Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulationLindsay K Nicholson, Harsh Pratap, Elisabeth Bowers, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudineJoseph E Rower, Amie Meditz, Edward M Gardner, et al.
AIDS Research and Human Retroviruses|October 21, 2014
Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected womenJose R Castillo-Mancilla, Kristina Searls, Patricia Caraway, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
AIDS (London, England)|January 26, 2017
Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infectionAlan R Lifson, Birgit Grund, Edward M Gardner, et al.
Open Forum Infectious Diseases|January 25, 2018
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART StudyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|July 26, 2019
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP CareKevin F Kamis, Grace E Marx, Kenneth A Scott, et al.
Journal of the International Association of Providers of AIDS Care|August 22, 2013
Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, ColoradoEdward M Gardner, Elaine Daniloff, Mark W Thrun, et al.
Immunobiology|September 17, 2018
Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulationLindsay K Nicholson, Harsh Pratap, Elisabeth Bowers, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudineJoseph E Rower, Amie Meditz, Edward M Gardner, et al.
AIDS Research and Human Retroviruses|October 21, 2014
Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected womenJose R Castillo-Mancilla, Kristina Searls, Patricia Caraway, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
AIDS (London, England)|January 26, 2017
Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infectionAlan R Lifson, Birgit Grund, Edward M Gardner, et al.
Open Forum Infectious Diseases|January 25, 2018
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART StudyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
Pageof 8